Medical Marijuana Use in a Community Cancer Center

Saadeh, Claire; Rustem, Danielle R.

doi:10.1200/jop.18.00057

Cited by 31 publications

(27 citation statements)

References 21 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…These reflect similar findings published regarding patients' reasons for marijuana use. 22,44 Our study also found that there was a trend for increased support in those who are younger and with worse symptoms, including appetite, fatigue, and anxiety. These findings suggest that patients who are more symptomatic might be more likely to seek alternative interventions such as marijuana in an attempt to seek relief.…”

Section: Discussionsupporting

confidence: 62%

“…14 An important consideration is that patients may be taking cannabinoids with other medications such as opioids, anxiolytics, antidepressants, and anticholinergics, which may lead to potentially serious interactions and should be discussed as an important element of safety. 44 Our findings showed that >50% of patients were not concerned about safety of MM. This is similar to a survey of medical oncologists who perceived that MM had a lower risk than opioids for addiction, overdose, and death, with 46% recommending marijuana for clinical use.…”

Section: Discussionmentioning

confidence: 61%

“…54 In contrast, the majority of our cancer patients had a positive attitude toward legalizing marijuana for medical use but not for recreational use, which is similar to findings by Pergam et al 22 This may reflect patient preferences of having a therapeutic indication and purpose before using a product rather than for coping alone, which is reflected in findings from a study on cancer patients undergoing chemotherapy. 44 On the other hand, this also points to the increasing belief of its medical usefulness from patients and families, even if the medical evidence is not yet robust. Our study is not able to identify factors that favor patients to have a more positive attitude toward medical use compared with recreational use.…”

Section: Discussionmentioning

confidence: 99%

See 2 more Smart Citations

Attitudes and Beliefs About Medical Usefulness and Legalization of Marijuana among Cancer Patients in a Legalized and a Nonlegalized State

Tanco

Dumlao²,

Kreis³

et al. 2019

Journal of Palliative Medicine

View full text Add to dashboard Cite

Background: There is a growing preference for the use of marijuana for medical purposes, despite limited evidence regarding its benefits and potential safety risks. Legalization status may play a role in the attitudes and preferences toward medical marijuana (MM). Objectives: The attitudes and beliefs of cancer patients in a legalized (Arizona) versus nonlegalized state (Texas) regarding medical and recreational legalization and medical usefulness of marijuana were compared.

show abstract

Section: Discussionsupporting

confidence: 62%

Section: Discussionmentioning

confidence: 61%

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

Attitudes and Beliefs About Medical Usefulness and Legalization of Marijuana among Cancer Patients in a Legalized and a Nonlegalized State

Tanco

Dumlao²,

Kreis³

et al. 2019

Journal of Palliative Medicine

View full text Add to dashboard Cite

show abstract

“…In fact, in one community oncology clinic, 18.3% of patients with cancer reported using cannabis in 2017. 6 In a Canadian study conducted in 2017, before cannabis was legalized in that country, 18% of patients with cancer used cannabis, often to relieve cancer-related pain, nausea, or other cancer symptoms. 7 Unfortunately, although 80% of clinicians are discussing cannabis (i.e., medical marijuana) with patients, only 30% feel adequately informed to make recommendations about its use.…”

Section: Introductionmentioning

confidence: 99%

Opportunities for cannabis in supportive care in cancer

Kleckner

Kamen

et al. 2019

Ther Adv Med Oncol

View full text Add to dashboard Cite

Cannabis has the potential to modulate some of the most common and debilitating symptoms of cancer and its treatments, including nausea and vomiting, loss of appetite, and pain. However, the dearth of scientific evidence for the effectiveness of cannabis in treating these symptoms in patients with cancer poses a challenge to clinicians in discussing this option with their patients. A review was performed using keywords related to cannabis and important symptoms of cancer and its treatments. Literature was qualitatively reviewed from preclinical models to clinical trials in the fields of cancer, human immunodeficiency virus (HIV), multiple sclerosis, inflammatory bowel disease, post-traumatic stress disorder (PTSD), and others, to prudently inform the use of cannabis in supportive and palliative care in cancer. There is a reasonable amount of evidence to consider cannabis for nausea and vomiting, loss of appetite, and pain as a supplement to first-line treatments. There is promising evidence to treat chemotherapy-induced peripheral neuropathy, gastrointestinal distress, and sleep disorders, but the literature is thus far too limited to recommend cannabis for these symptoms. Scant, yet more controversial, evidence exists in regard to cannabis for cancer- and treatment-related cognitive impairment, anxiety, depression, and fatigue. Adverse effects of cannabis are documented but tend to be mild. Cannabis has multifaceted potential bioactive benefits that appear to outweigh its risks in many situations. Further research is required to elucidate its mechanisms of action and efficacy and to optimize cannabis preparations and doses for specific populations affected by cancer.

show abstract

“…Three recent US studies surveyed patients about MC/marijuana use; 222 of 926 (24%), 32 of 175 (18.3%), and 83 of 299 (27%) used cannabis to control one or more symptoms, most commonly nausea or N/V, pain, appetite, insomnia, anxiety, dealing with stress, and depression ( Pergam et al, 2017 ; Saadeh & Rustem, 2018 ; Wilson, Masterson, & Broglio, 2019 ). When asked explicitly, patients wanted information about cannabis from their oncology providers (usually not provided).…”

Section: Supplementary Nondrug Measuresmentioning

confidence: 99%

Nausea and Vomiting Not Related to Cancer Therapy: Intractable Problem or Clinical Challenge?

Wickham¹

2020

JADPRO

View full text Add to dashboard Cite

Purpose Unlike therapy-related nausea and vomiting (chemotherapy or radiotherapy induced), nausea and vomiting (N/V) in patients with advanced cancer is often multicausal and thus presents unique challenges. Few professional guidelines address the palliative management of N/V, and those that do are insufficiently detailed to bolster clinical decision-making. Nonetheless, oncology advanced practitioners (APs) are frequently challenged to manage these high-impact symptoms. This requires collaborating with other oncology care providers and cultivating a knowledge base to educate and mentor professional colleagues to optimize N/V unrelated to treatment. Methods Literature reviewed included current and classic articles that address the physiologic bases of N/V related to disease and with malignant bowel obstruction, agents used to alleviate nausea or N/V, and nonpharmacologic adjunctive measures. This information was framed within palliative care and symptom management clinical experience. Results This review article summarizes what is known about the neuropharmacology of N/V in advanced disease. Focused assessment, pharmacologic agents (antiemetics, central neuromodulators, and peripheral prokinetic agents), and nondrug adjunctive measures that may be useful for N/V are included. Conclusions Managing N/V in advanced cancer is a quality-of-life imperative that requires persistence and interprofessional collaboration among oncology APs and other clinicians to personalize management. This work can change the perception that N/V related to progressive disease is frequently intractable to one that considers it as a manageable clinical challenge.

show abstract

Medical Marijuana Use in a Community Cancer Center

Abstract: Approximately one in five patients with cancer who were receiving chemotherapy were using marijuana, and the frequency was equal in early- and advanced-stage cancer groups. The risks versus benefits should be discussed with all patients who use marijuana.

Cited by 31 publications

References 21 publications

Attitudes and Beliefs About Medical Usefulness and Legalization of Marijuana among Cancer Patients in a Legalized and a Nonlegalized State

Attitudes and Beliefs About Medical Usefulness and Legalization of Marijuana among Cancer Patients in a Legalized and a Nonlegalized State

Opportunities for cannabis in supportive care in cancer

Nausea and Vomiting Not Related to Cancer Therapy: Intractable Problem or Clinical Challenge?

Contact Info

Product

Resources

About